Connecticut Considers Pharma Bill SB 270

Connecticut is considering SB 270, a bill that seeks to limit physician-pharmaceutical industry interaction.

Connecticut joins New York, Minnesota, and many other states by considering SB 270, a bill that seeks to limit physician-pharmaceutical industry interaction. During a debate in late February in a Public Health Committee hearing for the Connecticut General Assembly, the b

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish